• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Donate Now
  • Sign up for CMA’s weekly newsletter!

Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

  • Eligibility/Enrollment
  • Coverage/Appeals
    • Medicare Costs
    • Self Help Materials – Toolkits & More
  • Topics
    • Basic Introduction to Medicare
    • Medicare Costs
    • Home Health Care
    • Improvement Standard and Jimmo News
    • Nursing Home / Skilled Nursing Facility Care
    • Outpatient Observation Status
    • Part B
    • Part D / Prescription Drug Benefits
    • Medicare for People Under 65
    • Medicare “Reform”
    • All Other Topics
    • Resources
      • Infographics
  • Publications
    • CMA Alerts
    • Fact Sheets & Issue Briefs
    • Infographics
    • The Medicare Handbook
    • SNF Enforcement Newsletter
    • Elder Justice Newsletter
    • Medicare Facts & Fiction
    • Articles by Topic
  • Litigation
    • Litigation News
    • Cases
    • Litigation Archive
    • Amicus Curiae Activities
  • Newsroom
    • Press Releases
    • Editorials & Letters to the Editor
    • CMA Comments, Responses, and Letters
    • CMA in the News
  • About Us
    • National Voices of Medicare Summit
    • Mission Statement
    • CMA FAQs
    • CMA Annual Impact Report
    • Personnel & Boards
    • The Center for Medicare Advocacy Founder’s Circle
    • Connecticut Dually Eligible Appeals Project
    • Community Outreach and Education Project (COEP)
    • National Medicare Advocates Alliance
    • CMA Webinars
    • Products & Services
    • Testimonials
    • Career, Fellowship & Internship Opportunities
    • Contact Us
  • Support Our Work
    • Donate Now
    • Build a Legacy with CMA
    • Join the Center for Medicare Advocacy Founder’s Circle
    • Take Action
    • Share Your Health Care Story
    • Tell Congress to Protect Our Care
    • Listen to Medicare & Health Care Stories
    • Sign up for CMA’s weekly newsletter!

Minimal Social Security COLA Increase Will Likely Lead to Dramatic Part B Premium Increases for Some, Large Deductible Increase for All, Unless Congress Intervenes

October 19, 2016

Print Friendly, PDF & Email

On October 18, 2016, the Social Security Administration announced that the annual cost-of-living adjustment (COLA) will increase by only 0.3% in 2017.  Although Medicare premiums won’t be announced until later this Fall, as a result of this small increase to COLA, Part B premiums are projected to increase significantly.

A “hold-harmless” provision in the Medicare statute that protects against a reduction in Social Security benefits if the COLA is not large enough to cover the increase in the Part B premium will protect approximately 70% of beneficiaries who have their Part B premiums deducted from their Social Security checks.  The remaining 30%, including new enrollees, individuals who don’t have premiums deducted from their Social Security checks (including certain public retirees who don’t receive Social Security benefits), and higher income enrollees who are subject to the income-related premium will be subject to a higher premium in 2017 (as will states that pay premiums on behalf of individuals dually eligible for Medicare and Medicaid).   

Earlier this year, Medicare Trustees had projected that based on a lower 0.2% projected increase in the COLA, monthly Part B premiums in 2017 would be $149 (up from the standard premium in 2016 of $121).  The Trustees also projected an increase in the Part B deductible – which would also apply to those held harmless from premium increases – up to $204 from $166.

Medicare beneficiaries faced a similar scenario last year.  Congress intervened to mitigate much of the dramatic cost increases in 2016 for individuals by passing the Bipartisan Budget Act at the end of 2015.  See, for example:

  • House Passes Budget Agreement That Would Reduce Dramatic Rise in Part B Costs for Beneficiaries – Bill Moves to Senate; Advocates Remain Concerned About Underlying Causes (October 28, 2015
  • Budget Deal Averting Steep Part B Premium & Deductible Increases Signed Into Law (November 4, 2015)

The Center recently joined over 70 advocacy organizations, unions, health plans and others to urge Congress to intervene again this year in order to prevent similar, significant increases in costs. See the Joint letter to Congress submitted in September, 2016.

A Note Regarding “CPI-E”

Although the approach to reduce beneficiary costs taken in last year’s Bipartisan Budget Act would provide a short-term fix, it would not address some of the underlying problems with how the COLA is calculated relating to Medicare beneficiaries’ actual out-of-pocket expenses. One approach would be to change the way that the Consumer Price Index (CPI) is calculated by adopting a CPI for the elderly, or “CPI-E.”  See, for example:

  • Explanation of the CPI-E by the National Committee to Preserve Social Security and Medicare (NCPSSM) (March 2016)
  • Legislation that would, among other things, adopt the CPI-E: Congressman Larson’s “Social Security 2100 Act” (H.R. 1391)

Filed Under: Article Tagged With: Medicare Part B, Medicare Summary, Weekly Alert

Primary Sidebar

Easy Access to Understanding Medicare

The Center for Medicare Advocacy produces a range of informative materials on Medicare-related topics.
Sign Up for CMA's Free Newsletter
Register for CMA's Free Webinars

  • Medicare Basics
  • Medicare Reform
  • CMA Alerts
  • Fact Sheets & Issue Briefs
  • CMA Webinars
  • Connecticut Info & Projects
  • Health Care Stories
  • Se habla Español

Jimmo v. Sebelius

Medicare covers skilled care to maintain or slow decline as well as to improve.

Improvement Isn’t Required. It’s the law!

Read more.

National Voices of Medicare Summit

With the many threats currently facing the Medicare program, now is the time to come together as allies and explore ways to advocate for comprehensive Medicare coverage, health equity, and quality health care. Drawing inspiration from real-life experiences and stories of beneficiaries and caregivers, we hope to share impactful discussions with you.

Learn more.

Center for Medicare Advocacy Follow 10,542 5,336

A national nonpartisan, nonprofit law organization working to advance access to comprehensive #Medicare coverage and quality #healthcare.

CMAorg
CMAorg avatar Center for Medicare Advocacy @CMAorg ·
13 Mar 2032514309784220116

AI to fight Medicare fraud?

CMS is proposing new “CRUSH” rules using analytics and AI to flag suspicious claims.

But David Lipschutz of the Center for Medicare Advocacy warns medically necessary care could be caught in the crossfire.

More audits. More scrutiny. What does that

Reply on Twitter 2032514309784220116 Retweet on Twitter 2032514309784220116 1 Like on Twitter 2032514309784220116 1 X 2032514309784220116
Retweet on Twitter Center for Medicare Advocacy Retweeted
matthewherper avatar Matthew Herper @matthewherper ·
13 Mar 2032465053262196859

You can buy tickets to attend the STAT Breakthrough Summit East at this link:

Image for twitter card

STAT Summit East

agenda is now live  · agenda is now live  · agenda is now live  · agenda is now live  · agenda is now live  · agenda is now

www.statnews.com

Reply on Twitter 2032465053262196859 Retweet on Twitter 2032465053262196859 1 Like on Twitter 2032465053262196859 2 X 2032465053262196859
CMAorg avatar Center for Medicare Advocacy @CMAorg ·
12 Mar 2032166580935647730

Some retirees are being automatically enrolled into Medicare Advantage plans by former employers or unions — even if they didn’t actively choose the plan.

Our new issue brief examines how this happens and why it raises concerns about beneficiary choice.

Stay informed on

Reply on Twitter 2032166580935647730 Retweet on Twitter 2032166580935647730 1 Like on Twitter 2032166580935647730 1 X 2032166580935647730
Retweet on Twitter Center for Medicare Advocacy Retweeted
alsadvocacy avatar ALS Advocacy @alsadvocacy ·
11 Mar 2031652436721492445

How do we get access to the "leading ALS scientific conference?"

Image for twitter card

PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference

/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focu...

www.prnewswire.com

Reply on Twitter 2031652436721492445 Retweet on Twitter 2031652436721492445 1 Like on Twitter 2031652436721492445 2 X 2031652436721492445
Load More

Footer

Stay Connected:

  • Contact Us
  • Sitemap
  • Products & Services
  • Copyright/Privacy

© 2026 · Center for Medicare Advocacy